About Kunming Longjin Pharmaceutical Company

The company was founded on September 16, 1996. “Longjin prospers a healthy life” - this is the original intention of Longjin Pharmaceutical. Longjin Pharmaceutical's mission is to protect lives, improve human health, and share a comfortable life. We have always adhered to the values of ingenuity, win-win, innovation, honesty and pragmatism. Longjin Pharmaceutical is committed to becoming an industry leader with an innovative spirit, respected by the world, and trusted by partners for a long time. The main business is to engage in R&D, production and sales of modern proprietary Chinese medicines and high-end chemical generic drugs. The company's main products include proprietary Chinese medicines and chemical generics. The representative products on sale include pharmaceuticals such as dengzhanhuacin for injection, and somatostatin for injection. The dosage forms are all freeze-dried powder injections, which are mainly used for the treatment of cardiovascular, cerebrovascular and endocrine diseases; the products the company is developing are also high-end chemosimals and innovative drugs focused on the aforementioned treatment fields. The dosage forms are mainly oral solid formulations. Corporate honors: Famous trademarks and invention patents in Yunnan Province, 2017 Best Process Innovation Award, 2017 Kunming Famous Brand, “Outstanding Chinese Medicine Brand Enterprise”, “China's Top 100 Traditional Chinese Medicine Enterprises”, “China's Top 100 Pharmaceutical Industry Series List”, “Yunnan Top 100 Non-public Enterprises”, “2023 Yunnan Top 100 High-tech Enterprises”, “Kunming Health Enterprise”, “Typical Case of Digital Transformation of Listed Companies in 2023”, etc.